Evidence map›Paper›PMID 33170180›Full record

ArticleActa bio-medica : Atenei Parmensis2020

Prenatal genetic diagnosis: Fetal therapy as a possible solution to a positive test.

Aysha Karim Kiani, Stefano Paolacci, Pietro Scanzano, Sandro Michelini, Natale Capodicasa, Leonardo D'Agruma, Angelantonio Notarangelo, Gerolamo Tonini, Daniela Piccinelli, Kalantary Rad Farshid and 11 more

Open access · greenAbstract read
In one paragraph

Article in Acta bio-medica : Atenei Parmensis, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Non-Invasive Prenatal Testing (NIPT): A Paradigm Shift in Prenatal Care.International journal of preventive medicine · 2025
    Review
  3. Observational
  4. Dietary supplements in lymphedema.Journal of preventive medicine and hygiene · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 11 institutions in 3 countries.

Aysha Karim KianiMAGI EUREGIO, Bolzano, Italy. ayshakiani@gmail.com.
Stefano PaolacciMAGI'S LAB. stefano.paolacci@assomagi.org.
Pietro ScanzanoSan Giovanni Battista Hospital, Rome, Italy. p.scanzano@acismom.it.
Sandro MicheliniDepartment of Rehabilitation, San Giovanni Battista Hospital, Rome, Italy. s.michelini@acismom.it.
Natale CapodicasaMAGI Balkans, Tirana, Albania. ncapodicasa@yahoo.it.
Leonardo D'AgrumaDivision of Medical Genetics, Fondazione IRCCS-Casa Sollievo della Sofferenza, San Giovanni Rotondo (FG), Italy. l.dagruma@operapadrepio.it.
Angelantonio NotarangeloDivision of Medical Genetics, Fondazione IRCCS-Casa Sollievo della Sofferenza, San Giovanni Rotondo (FG), Italy. a.notarangelo@operapadrepio.it.
Gerolamo ToniniSurgical Department, Unit of Urology, Poliambulanza Foundation, Brescia, Italy. gerolamotonini@libero.it.
Daniela PiccinelliDepartment of Mother and Child Health, Unit of Obstetrics and Gynecology, Poliambulanza Foundation, Brescia, Italy. daniela.piccinelli@poliambulanza.it.
Kalantary Rad FarshidSurgical Department, Unit of Urology, Poliambulanza Foundation, Brescia, Italy. farshid.kalantaryrad@poliambulanza.it.
Paolo PetraliaIRCCS Giannina Gaslini Institute, Genoa, Italy. paolopetralia@gaslini.org.
Ezio FulcheriUOSD Fetal and Perinatal Pathology, Department of Translational Research, Laboratory Medicine, Diagnostics and Services, IRCCS Giannina Gaslini Institute, Genoa, Italy. eziofulcheri@gaslini.org.
Francesca BuffelliUOSD Fetal and Perinatal Pathology, Department of Translational Research, Laboratory Medicine, Diagnostics and Services, IRCCS Giannina Gaslini Institute, Genoa, Italy. francescabuffelli@gaslini.org.
Pietro ChiurazziIstituto di Medicina Genomica, Università Cattolica del Sacro Cuore, Rome, Italy; UOC Genetica Medica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome Italy. pietrosmile@yahoo.com.
Corrado TerranovaUniversity Campus Bio Medico of Rome, Department of Obstetrics and Gynecology, Rome, Italy. C.Terranova@unicampus.it.
Francesco PlottiUniversity Campus Bio Medico of Rome, Department of Obstetrics and Gynecology, Rome, Italy. f.plotti@unicampus.it.
Roberto AngioliUniversity Campus Bio Medico of Rome, Department of Obstetrics and Gynecology, Rome, Italy. R.Angioli@unicampus.it.
Marco CastoriDivision of Medical Genetics, Fondazione IRCCS-Casa Sollievo della Sofferenza, San Giovanni Rotondo (FG), Italy. m.castori@operapadrepio.it.
Ondrej PösDepartment of Molecular Biology, Faculty of Natural Sciences, Comenius University, Bratislava, Slovakia; Geneton Ltd., Bratislava, Slovakia. pos1@uniba.sk.
Tomas Szemes14 Department of Molecular Biology, Faculty of Natural Sciences, Comenius University, Bratislava, Slovakia; Geneton Ltd., Bratislava, Slovakia; Comenius University Science Park, Bratislava, Slovakia. tomas.szemes@geneton.sk.
Matteo BertelliMAGI EUREGIO, Bolzano, Italy; MAGI'S LAB, Rovereto (TN), Italy; EBTNA-LAB, Rovereto (TN), Italy. matteo.bertelli@assomagi.org.
Casa Sollievo della Sofferenza · ITFondazione Poliambulanza Istituto Ospedaliero · ITIstituto Giannina Gaslini · ITUniversità Campus Bio-Medico · ITAzienda Ospedaliero Universitaria San Giovanni Battista · ITComenius University Bratislava · SKCenter for Neuroscience and Cognitive Systems · ITEurac Research · ITOspedale Maggiore · ITUniversità Cattolica del Sacro Cuore · ITYahoo (United Kingdom) · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFetal abnormalities cause 20% of perinatal deaths. Advances in prenatal genetic and other types of screening offer great opportunities for identifying high risk pregnancies.

methodsThrough a literature search, here we summarise what are the prenatal diagnostic technique that are being used and how those techniques may allow for prenatal interventions.

resultsNext generation sequencing and non-invasive prenatal testing are fundamental for clinical diagnostics because of their sensitivity and accuracy in identifying point mutations, aneuploidies, and microdeletions, respectively. Timely identification of genetic disorders and other fetal abnormalities enables early intervention, such as in-utero gene therapy, fetal drug therapy and prenatal surgery.

conclusionPrenatal intervention is mainly focused on conditions that may cause death or lifelong disabilities, like spina bifida, congenital diaphragm hernia and sacrococcygeal teratoma; and may be an alternative therapeutic option to termination of pregnancy. However, it is not yet widely available, due to lack of specialized centers.

Indexed as

Fetal TherapiesHernias, Diaphragmatic, CongenitalAneuploidyFemaleHumansPregnancyPrenatal Diagnosis

Identifiers

PMID33170180
PMCPMC8023142
OpenAlexW3102071924

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.